Clinical characteristics and management of dasatinib-induced chylothorax: retrospective analysis based on case reports
Dasatinib-induced chylothorax is rare but often reversible. Early diagnosis, drug discontinuation, and appropriate supportive care are key to recovery. Rechallenge should be undertaken cautiously due to a high risk of recurrence.
Authors
- Yixiang Hu (ORCID: https://orcid.org/0000-0001-8697-644X)
- Xiang Liu (ORCID: https://orcid.org/0000-0002-8451-3465)
- Ya Liu (ORCID: https://orcid.org/0000-0001-7262-8161)
- Ying Huang (ORCID: https://orcid.org/0000-0001-6606-7935)
Institutions
- Hunan University (CN)
- Xiangyang Central Hospital (CN)
- Zhongshan Hospital (CN)
- Jinan Stomatological Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fphar.2025.1665484
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Hunan Province
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province